Search research articles
Contact Us
Filters
Showing results (101-110 of 105) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 105 results.
RSC Medicinal Chemistry
|
April 21, 2025
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease
Gui-Long Tian, Chia-Ju Hsieh, Dinahlee Saturnino Guarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis
Karen Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
BMC Cancer
|
February 6, 2022
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Alexander Schmitz, Rasmus Froberg Brøndum, Hans Erik Johnsen, et al.
Blood Advances
|
September 27, 2018
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
Julie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, et al.
Haematologica
|
February 13, 2008
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C Rawstron, Alberto Orfao, Meral Beksac, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 105) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 105 results.
RSC Medicinal Chemistry
|
April 21, 2025
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease
Gui-Long Tian, Chia-Ju Hsieh, Dinahlee Saturnino Guarino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis
Karen Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
BMC Cancer
|
February 6, 2022
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
Alexander Schmitz, Rasmus Froberg Brøndum, Hans Erik Johnsen, et al.
Blood Advances
|
September 27, 2018
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
Julie Støve Bødker, Rasmus Froberg Brøndum, Alexander Schmitz, et al.
Haematologica
|
February 13, 2008
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C Rawstron, Alberto Orfao, Meral Beksac, et al.
Page
of 11